D12331, D12330

超高脂肪飼料D12330・D12331(58kcal% 脂肪含有量、ココナッツオイル使用)

D12331
58kcal% Fat、炭水化物にスクロース使用
D12330
58kcal% Fat、炭水化物にコーンスターチ使用

Surwit Dietとしても知られています。

コントロール飼料(低脂肪 コントロール飼料、10kcal% 脂肪含有量、違いは炭水化物の原料のみ)

D12328
10kcal% Fat、炭水化物にコーンスターチ使用
D12329
10kcal% Fat、炭水化物にスクロース使用

脂肪含有量や脂肪原料、各種原料のご指定などオーダーメイドが可能です。
その他の油脂原料を使った飼料はこちら
詳しくはこちらよりお問合せください。

研究領域 (例)

肥満・糖尿病、その他

形状

固形・粉末

使用上の注意

高脂肪飼料(D12330・D12331)の固形飼料:
冷凍保存推奨 週2回ほど交換推奨
高脂肪飼料(D12330・D12331)の粉末飼料:
冷蔵保存推奨 週2回ほど交換推奨

低脂肪 コントロール飼料(D12328・D12329)は、固形・粉末どちらも常温保存可能 ※高温多湿を避けてください
※成分を均一に保つ為、粉末飼料は飼料交換の都度袋の底から全体を混ぜてください。
飼料交換回数について リサーチダイエット社ブログより

対応動物種

マウス ラット ハムスター

参考論文・資料

関連論文については、お気軽にこちらよりお気軽にお申し付けください。

リサーチダイエット社ホームページより

Updated: May 08, 2012

  1. Baffy, G., et al. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology. 35:753-761, 2002.
  2. Bale, T.L., et al. Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology.
  3. Brownlow, B., et al. The role of motor activity in diet-induced obesity in C57BL/6J mice. Physiology & Behavior. 60:37-41, 1996.
  4. Collins, Sheila & Surwit, Richard. Pharmacologic manipulation of ob expression in a dietary model of obesity. The Journal of Biological Chemistry. 271:9437-9440, 1996.
  5. Collins, S., et al. Genetic variation to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiology & Behavior. 81:243-248, 2004.
  6. Fruebis, J., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and cause weight loss in mice. PNAS. 98:2005-2010, 2001.
  7. Gimmeno, R.E., et al. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. The Journal of Biological Chemistry. 278:49512-49516,2003.
  8. Guerra, C., et al. Emergence of brown adipocytes in white fat mice is under genetic control. Journal of Clinical Investigation. 102:412-420, 1998.
  9. Hohmann, J.G., et al. Obesity and endocrine dysfunction in mice with deletions of both neuopeptide Y and galanin. Molecular and Cellular Biology. 24:2978-2985, 2004.
  10. Ishihara, Y., et al. Effects of diet and time of day on serum and CSF leptin levels in Osborne-Mendel and S5B/PI rats. Obesity Research. 12:1067-1076, 2004.
  11. Kim, J., et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. The Journal of Clinical Investigation. 113:756-763, 2004.
  12. Liu, X., et al. Paradoxical resistance to diet-induced obesity in UCP1-deficient mice. Journal of Clinical Investigation. 111:399-407, 2003.
  13. Morton, N., et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11ß-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes. 53:931-938, 2004.
  14. Münzberg, H. Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology. 145:4880-4889, 2004.
  15. Paterson , J.M., et al. Metabolic syndrome without obesity: hepatic overexpression of 11ß-hydroxysteroid dehydrogenase type 1 in transgenic mice. PNAS. 101:7088-7093, 2004.
  16. Petro, A.E., et al. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism. 53:454-457,2004.
  17. Pittner, RA, Effects of PYY[3-36] in rodent models of diabetes and obesity. International Journal of Obesity. 28:963-971, 2004.
  18. Prpic, V., et al. Differential Mechanisms and development of leptin resistance in A/J versus C57BL/6J mice during diet-induced obesity. Endocrinology. 144:1155-1163, 2002.
  19. Prpic, V., et al. Adaptive changes in adipocyte gene expression differ in AKR/J and SWR/J mice during diet induced obesity. Journal of Nutrition. 132:3325-3332, 2002.
  20. Rossmeisl, M., et al. Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity. Diabetes. 52:1958-1966, 2003.
  21. Surwitt, R.S., et al. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc. Natl. Acad. Sci. USA . 95:4061-4065, 1998.
  22. Szcypka, M.S., et al. Feeding behavior in dopamine-deficient mice. PNAS. 96:12138-12143, 1999.
  23. Tsai, Yau-Sheng, et al. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPAR?. The Journal for Clinical Investigation. 114:241-249, 2004.
  24. Tsukiyama-Kohara, Kyoko, et al. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nature Medicine. 7:1128-1132, 2001.
  25. Vigliotta, G., et al. Overexoression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Molecular and Cellular Biology. 24:5005-5015, 2004.
  26. Williams. T.D., et al. Diet-induced obesity and cardiovascular regulation in C57BL/6J mice. Clinical and Experimental Pharmacology and Physiology. 30:769-778, 2003.
  27. Yu, X.X., et al. Characterization of a novel UCP5/BMCP1 isoforms and differential regulation of UCP$ and UCP5 expression through dietary or temperature manipulation. FASEB J. 14:1611-1618, 2000.
  28. Yuan, M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKß . Science. 293:1673-1677, 2001.
  29. Zvonic, Sanjin, et al. The regulation and activatin of ciliary neurotrophic factor signaling proteins in adipocytes. The Journal of Biological Chemistry. 278:2228-2235, 2003.
  30. Surwit RS, et al. Differential effects of fat and sucrose on body composition in A/J and C57BL/6 mice. Metabolism.. 1998;47:1354-9.
  31. Surwit RS, et al. Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism.. 1998;47:1089-96.
  32. Surwit RS, et al. Pharmacologic manipulation of ob expression in a dietary model of obesity. J Biol Chem.. 1996; 271:9437-40.
  33. Surwit RS, et al. Differential Effects of Fat and Sucrose on the Development of Obesity and Diabetes in C57BL/6J and A/J Mice. Metabolism. 1995; 44:645-651.
  34. Watson P, Commins S, Beiler R, Hatcher H & Gettys T. Differential regulation of leptin expression and function an A/J vs C57BL/6J mice during diet-induced obesity.Am J Physiol Endocrinol Metab. 2000: 279; E356-365.
  35. Guerre-Millo M, Gervois P, Raspe E, Madsen L, Poulain P, Derudas B, Herbert J, Winegar D, Willson T, Fruchart J, Berge R & Staels B. Peroxisome Proliferator-activated Receptor Alpha Activators Improve Insulin Sensitivity and Reduce Adiposity. JBC. 2000: 275; 16638-16642
  36. Lenhard J, Croom D, Weiel J, Spaltenstein A, Reynolds D & Furfine E. Dietary Fat Alters HIV Protease Inhibitor-Induced Metabolic Changes in Mice. J Nutr. 2000: 130; 2361-2366
  37. Surwit RS, Dixon T, Petro A, Daniel K & Collins S. Diazoxide Restores Beta-three Adrenergic Receptor Function in Diet-Induced Obesity and Diabetes. Endocrinol. 2000: 141; 3630-3637
  38. Bachman ES, Dhillon H, Zhang C, Cinti S, Bianco AC, Kobilka BK & Lowell BB.ßAR Signaling Required for Diet-Induced Thermogenesis and Obesity Resistance. Science. 297:843-845. 2002
  39. Hofmann, SM, et al. Defective Lipid Delivery Modulates Glucose Tolerance and Metabolic Response to Diet in Apolipoprotein E–Deficient Mice. Diabetes 57:5–12, 2008.
  40. Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, Witters LA, Kemp BE, Means AR. Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab. 2008 May;7(5):377-88.
  41. Bhattacharya I, Mundy AL, Widmer CC, Kretz M, Barton M. Regional heterogeneity of functional changes in conduit arteries after high-fat diet. Obesity (Silver Spring). 2008 Apr;16(4):743-8. Epub 2008 Jan 24.
  42. Buchner DA, Burrage LC, Hill AE, Yazbek SN, O'Brien WE, Croniger CM, Nadeau JH. Resistance to diet-induced obesity in mice with a single substituted chromosome. Physiol Genomics. 2008 Sep 17;35(1):116-22. Epub 2008 Jul 15.
  43. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5266-70. Epub 2008 Mar 24.
  44. Harrington WW, S Britt C, G Wilson J, O Milliken N, G Binz J, C Lobe D, R Oliver W, C Lewis M, M Ignar D. The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice. PPAR Res. 2007;2007:97125.
  45. Hofmann SM, Perez-Tilve D, Greer TM, Coburn BA, Grant E, Basford JE, Tschöp MH, Hui DY. Defective lipid delivery modulates glucose tolerance and metabolic response to diet in apolipoprotein E-deficient mice. Diabetes. 2008 Jan;57(1):5-12. Epub 2007 Oct 3.
  46. Lee DF, Kuo HP, Chen CT, Wei Y, Chou CK, Hung JY, Yen CJ, Hung MC. IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med. 2008 Nov;22(5):633-8.
  47. Li JZ, Ye J, Xue B, Qi J, Zhang J, Zhou Z, Li Q, Wen Z, Li P. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes. 2007 Oct;56(10):2523-32. Epub 2007 Jul 23.
  48. Mack C, Wilson J, Athanacio J, Reynolds J, Laugero K, Guss S, Vu C, Roth J, Parkes D. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am J Physiol Regul Integr Comp Physiol. 2007 Nov;293(5):R1855-63. Epub 2007 Sep 12.
  49. Metlakunta AS, Sahu M, Sahu A. Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice. Endocrinology. 2008 Mar;149(3):1121-8. Epub 2007 Nov 29.
  50. Miele C, Raciti GA, Cassese A, Romano C, Giacco F, Oriente F, Paturzo F, Andreozzi F, Zabatta A, Troncone G, Bosch F, Pujol A, Chneiweiss H, Formisano P, Beguinot F. PED/PEA-15 regulates glucose-induced insulin secretion by restraining potassium channel expression in pancreatic beta-cells. Diabetes. 2007 Mar;56(3):622-33.
  51. Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, Drel VR. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. Diabetes. 2007 Oct;56(10):2598-608. Epub 2007 Jul 12.
  52. Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K. The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology. 2008 May;149(5):2208-18. Epub 2008 Jan 31.
  53. Tsao D, Thomsen HK, Chou J, Stratton J, Hagen M, Loo C, Garcia C, Sloane DL, Rosenthal A, Lin JC. TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology. 2008 Mar;149(3):1038-48. Epub 2007 Dec 6.

DIO飼料 リサーチダイエット社の紹介ページはこちら

お問合せはこちらまで

▲ページトップへ